Segall Bryant & Hamill’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,632
| Closed | -$3.05M | – | 736 |
|
|
2023
Q1 | $3.05M | Buy |
13,632
+12
| +0.1% | +$2.69K | 0.03% | 395 |
|
|
2022
Q4 | $3.79M | Sell |
13,620
-4,859
| -26% | -$1.35M | 0.04% | 363 |
|
|
2022
Q3 | $3.87M | Buy |
18,479
+975
| +6% | +$204K | 0.05% | 351 |
|
|
2022
Q2 | $4.12M | Sell |
17,504
-3,992
| -19% | -$941K | 0.05% | 350 |
|
|
2022
Q1 | $3.86M | Sell |
21,496
-2,342
| -10% | -$420K | 0.04% | 366 |
|
|
2021
Q4 | $5.15M | Buy |
23,838
+570
| +2% | +$123K | 0.05% | 320 |
|
|
2021
Q3 | $4.3M | Buy |
23,268
+931
| +4% | +$172K | 0.04% | 360 |
|
|
2021
Q2 | $4.01M | Buy |
+22,337
| New | +$4.01M | 0.04% | 366 |
|